Gujarat Based-Penny Stock Under Rs 2 Hit Back-To-Back Upper Circuits; Board Announces 1:2 Stock Split
The stock is trading at 0.48 times its book value and the stock is up by 59 per cent from its 52-week low of Rs 1.04 per share.
On Friday, shares of Murae Organisor Limited (Formerly known as Earum Pharmaceuticals Limited) hit a 5 per cent upper circuit to Rs 1.65 per share from its previous closing of Rs 1.58 per share. The stock’s 52-week high is Rs 2.73 per share and its 52-week low is Rs 1.04 per share. The shares of the company saw a spurt in volume by more than 7 times on the BSE.
Murae Organisor Limited hereby informs that at the Board Meeting held on Thursday, April 24, 2025, the Board of Directors approved a 1:2 stock split, subject to shareholder approval, where each equity share with a face value of Rs 2 will be subdivided into two equity shares with a face value of Rs 1 each, to enhance the liquidity of the company's shares and make them more accessible to retail investors; the pre-split subscribed and paid-up share capital of Rs 1,85,89,64,310 divided into 9,29,48,21,55 shares of Rs 2 each will become Rs 1,85,89,64,310 divided into 1,85,89,64,310 shares of Rs 1 each, and the company anticipates the completion of this process within approximately two months for the existing class of equity shares.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
Murae Organisor Ltd., incorporated in 2012, operates within the pharmaceutical industry, focusing on the marketing, trading, and distribution of a diverse range of pharmaceutical formulations. The company markets over 120 products under its brand names, such as HYGNEX+, Erolon, and Calcybar, while outsourcing its manufacturing to third-party facilities. In addition to their branded products, Murae also trades in active pharmaceutical ingredients. Their product portfolio spans various therapeutic categories, including antibiotics, antimalarials, antihistamines, analgesics, dermatology products, neurological drugs, gastrointestinal drugs, and various supplements like calcium and multivitamins. Murae maintains an international presence, exporting to more than 15 countries across North America, CIS, Latin America, Africa, and Southeast Asia, with over 60 international products currently under registration.
The company has a market cap of Rs 153 crore and its 100 per cent stake is owned by public shareholders. The stock is trading at 0.48 times its book value and the stock is up by 59 per cent from its 52-week low of Rs 1.04 per share.
Disclaimer: The article is for informational purposes only and not investment advice.